Flow Cytometry Market worth .3 billion by 2026 - Exclusive Report by MarketsandMarkets™

Posted by snehal shaha on August 4th, 2022

The Growth in the flow cytometry market is largely driven by the rising global incidence and prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, increasing incorporation of AI platforms in flow cytometry workflows, and increasing advancements in flow cytometry software. However, the high cost of flow cytometry products is a major factor hampering the growth of the market.

The flow cytometry market is expected to register a CAGR of 8.1% to reach USD 6.3 Billion in 2026 from USD 4.3 Billion in 2021. 

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Scope of the Report

This research report categorizes the flow cytometry market based on technology, product and service, application, end user, and region.

By Technology

• Cell-based Flow Cytometry
• Bead-based Flow Cytometry

By Product and Service

• Reagents and Consumables
• Instruments
• Cell Analyzers
• High-range
• Mid-range
• Low-range
• Cell Sorters
• High-range
• Mid-range
• Low-range
• Services
• Software
• Accessories

By Application

• Research Applications
• Pharmaceuticals and Biotechnology
• Drug Discovery
• Stem Cell Research
• In Vitro Toxicity Testing
• Immunology
  
• Apoptosis
• Cell Cycle Analysis
• Cell Viability
• Cell Counting
• Other Research Applications
• Clinical Applications
• Cancer Diagnostics
• Hematology
• Autoimmune Diseases
• Organ Transplantation
• Other Clinical Applications
• Industrial Applications

By End User

• Academic & Research Institutes
• Hospitals & Clinical Testing Laboratories
• Pharmaceutical & Biotechnology Companies

By Region

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of the Asia Pacific (RoAPAC)
• Latin America
• Brazil
• Mexico
• Rest of Latin America (Rest of LATAM)
• Middle East and Africa

Market Segmentation:-

On the basis of technology, the global flow cytometry market is segmented into cell-based and bead-based flow cytometry. The bead-based flow cytometry segment is estimated to witness the highest growth during the forecast period. This technology offers various procedural advantages over other cell-based assays, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.

In this report, the flow cytometry market for clinical applications is segmented into organ & tissue transplantations, cancer diagnostics, immunodeficiency diseases, hematology, and other clinical applications. Flow cytometry can be applied to cancer studies at every stage by measuring the amount of DNA in cancer cells, analyzing tumor cell proliferation, and immunophenotyping hematological malignancies. In addition, flow cytometry tools are used to determine the malignancy of a tumor by analyzing and enumerating a number of chromosomes and can thus be used to detect cancerous cells.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584

Regional Analysis: -

In 2020, the Asia Pacific region accounted for the fasted growing region of the market. The APAC market is expected to offer significant growth opportunities to key market players during the forecast period. Countries in this region are witnessing sustained growth in their GDPs and the disposable incomes of their middle-class population.

Top Key Players: -

The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies, Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux S.A. (France), Cytonome/ ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences, Inc. (US), Union Biometrica, Inc. (US), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).